{Boc}-Phe-Leu-Phe-Leu-Phe (TFA)

{Boc}-Phe-Leu-Phe-Leu-Phe (TFA)

• UNSPSC Description: {Boc}-Phe-Leu-Phe-Leu-Phe TFA is a formyl peptide receptor (FPR) family antagonist that preferentially inhibits activity triggered through the formyl peptide receptor[1].
• Target Antigen: Formyl Peptide Receptor (FPR)
• Type: Peptides
• Related Pathways: GPCR/G Protein
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/boc-phe-leu-phe-leu-phe-tfa.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(O)[C@H](CC1=CC=CC=C1)NC([C@@H](CC(C)C)NC([C@H](CC2=CC=CC=C2)NC([C@@H](CC(C)C)NC([C@H](CC3=CC=CC=C3)NC(OC(C)(C)C)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O
• Molecular Weight: 899.99
• References & Citations: [1]Anna-Lena Stenfeldt, et al. Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor. Inflammation. 2007 Dec;30(6):224-9.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported